Novita Pharmaceuticals, Inc. ("Novita"), a privately held, clinical-stage pharmaceutical company dedicated to developing novel cancer drugs through its proprietary fascin inhibitor technology, today ...

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk o ...

The Dairy Innovation Hub held its fourth annual Dairy Symposium on May 14 at UW–Madison’s Memorial Union. More than 250 ...

Clinicians and scientists from RWJBarnabas Health and Rutgers Cancer Institute will share new findings and lead discussions ...

Skywork ( unveiled Skywork Super Agents to the global market. This cutting-edge product leverages AI agent architecture and deep research technology to provide an all-in-one solution for generating ...

More than in other disciplines, success depends on a few high-stakes events. Job-market candidates are evaluated on a single ...

Sanofi today announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboration and innovation with the ultimate goal of ...

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, ...

IndusInd Bank is investigating former key management personnel for potential accounting fraud, leading to a significant net loss of ₹2,328 crore in Q4 and a 71% drop in FY25 net profit. The probe ...